Seattle Genetics | L'Utile Ante Imposte



L'Utile Ante Imposte Cambiamento Data
AbbVie USD 4.38B 1.92B 2025-09
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Amgen USD 3.92B 2.35B 2025-09
Astellas Pharma JPY 133.96B 29.77B 2025-12
Bayer EUR -1.16B 735M 2025-09
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Celldex Therapeutics USD -67.04M 10.44M 2025-09
Daiichi Sankyo JPY 106.73B 48.96B 2025-12
Eisai JPY 22B 7.47B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Exelixis USD 252.69M 275K 2025-12
Genmab DKK 482M 59M 2025-09
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Glaxosmithkline GBP 2.46B 569M 2025-09
Incyte USD 389.94M 92.37M 2025-12
Insmed USD -368.7M 48.26M 2025-09
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
MacroGenics USD 16.82M 52.97M 2025-09
Merck USD 6.74B 22M 2025-09
Moderna USD -187M 631M 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Novartis USD 4.2B 335M 2025-09
Pfizer USD 3.33B 290M 2025-09
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
Takeda JPY 133.86B 105.69B 2025-12
Teva Pharmaceutical Industries USD 91M 555M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Xencor USD -6.03M 25.05M 2025-09


Seattle Genetics L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.